BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 36464269)

  • 21. The role of depression in the relationship between cognitive decline and quality of life among breast cancer patients.
    Park JH; Jung YS; Jung YM; Bae SH
    Support Care Cancer; 2019 Jul; 27(7):2707-2714. PubMed ID: 30498990
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigating Relationship between Pre- and Post- Chemotherapy Cognitive Performance with Levels of Depression and Anxiety in Breast Cancer Patients: A Cross-Sectional Study.
    Hormozi M; Hashemi SM; Shahraki S
    Asian Pac J Cancer Prev; 2019 Dec; 20(12):3831-3837. PubMed ID: 31870129
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluating cognitive complaints in breast cancer survivors with the FACT-Cog and quantitative electroencephalography.
    Van Dyk K; Hunter AM; Ercoli L; Petersen L; Leuchter AF; Ganz PA
    Breast Cancer Res Treat; 2017 Nov; 166(1):157-166. PubMed ID: 28707203
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Psychometric properties and measurement equivalence of the English and Chinese versions of the functional assessment of cancer therapy-cognitive in Asian patients with breast cancer.
    Cheung YT; Lim SR; Shwe M; Tan YP; Chan A
    Value Health; 2013; 16(6):1001-13. PubMed ID: 24041350
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pain, psychological distress, health status, and coping in patients with breast cancer scheduled for autotransplantation.
    Gaston-Johansson F; Ohly KV; Fall-Dickson JM; Nanda JP; Kennedy MJ
    Oncol Nurs Forum; 1999 Sep; 26(8):1337-45. PubMed ID: 10497773
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuropsychological functioning in postmenopausal breast cancer patients treated with tamoxifen or exemestane after AC-chemotherapy: cross-sectional findings from the neuropsychological TEAM-side study.
    Schilder CM; Eggens PC; Seynaeve C; Linn SC; Boogerd W; Gundy CM; Beex LV; Van Dam FS; Schagen SB
    Acta Oncol; 2009; 48(1):76-85. PubMed ID: 18777410
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Perceived cognitive impairment in people with colorectal cancer who do and do not receive chemotherapy.
    Dhillon HM; Tannock IF; Pond GR; Renton C; Rourke SB; Vardy JL
    J Cancer Surviv; 2018 Apr; 12(2):178-185. PubMed ID: 29080061
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quality of working life can protect against cognitive and emotional vulnerability in women living with metastatic breast cancer: a cross-sectional study.
    Chapman B; Grunfeld EA; Derakshan N
    J Cancer Surviv; 2023 Oct; 17(5):1295-1308. PubMed ID: 35038120
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Perceived cognitive function in breast cancer survivors: evaluating relationships with objective cognitive performance and other symptoms using the functional assessment of cancer therapy-cognitive function instrument.
    Von Ah D; Tallman EF
    J Pain Symptom Manage; 2015 Apr; 49(4):697-706. PubMed ID: 25240787
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fatigue, anxiety and depression overrule the role of oncological treatment in predicting self-reported health complaints in women with breast cancer compared to healthy controls.
    Hagen KB; Aas T; Kvaløy JT; Eriksen HR; Søiland H; Lind R
    Breast; 2016 Aug; 28():100-6. PubMed ID: 27262826
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quality of life and psychological well-being of breast cancer survivors in Jordan.
    Abu-Helalah M; Al-Hanaqta M; Alshraideh H; Abdulbaqi N; Hijazeen J
    Asian Pac J Cancer Prev; 2014; 15(14):5927-36. PubMed ID: 25081724
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictors of health-related quality of life after completion of chemotherapy among Malaysian early-stage breast cancer survivors.
    Syed Alwi SM; Narayanan V; Mohd Taib NA; Che Din N
    Support Care Cancer; 2022 Mar; 30(3):2793-2801. PubMed ID: 34841453
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Intervention focused on resources to reduce anxiety and depression disorders in cancer patients: A pilot study].
    Lantheaume S; Montagne M; Shankland R
    Encephale; 2020 Feb; 46(1):13-22. PubMed ID: 31610923
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Perceived cognitive impairment in Chinese patients with breast cancer and its relationship with post-traumatic stress disorder symptoms and fatigue.
    Li J; Yu L; Long Z; Li Y; Cao F
    Psychooncology; 2015 Jun; 24(6):676-82. PubMed ID: 25345397
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cancer treatment effects on cognition and depression: The moderating role of physical activity.
    Bedillion MF; Ansell EB; Thomas GA
    Breast; 2019 Apr; 44():73-80. PubMed ID: 30685529
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of EEG biofeedback on reducing postcancer cognitive impairment.
    Alvarez J; Meyer FL; Granoff DL; Lundy A
    Integr Cancer Ther; 2013 Nov; 12(6):475-87. PubMed ID: 23584550
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of age on Health-Related Quality of Life (HRQoL) and symptoms among postmenopausal women with breast cancer receiving adjuvant chemotherapy.
    Browall MM; Ahlberg KM; Persson LO; Karlsson PO; Danielson EB
    Acta Oncol; 2008; 47(2):207-15. PubMed ID: 18210297
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The psychometric properties of the Korean version of the functional assessment of cancer therapy-cognitive (FACT-Cog) in Korean patients with breast cancer.
    Park JH; Bae SH; Jung YS; Jung YM
    Support Care Cancer; 2015 Sep; 23(9):2695-703. PubMed ID: 25666997
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impacts of breast cancer and chemotherapy on gut microbiome, cognitive functioning, and mood relative to healthy controls.
    Bilenduke E; Sterrett JD; Ranby KW; Borges VF; Grigsby J; Carr AL; Kilbourn K; Lowry CA
    Sci Rep; 2022 Nov; 12(1):19547. PubMed ID: 36380060
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of physical exercise on cognitive function after chemotherapy in patients with breast cancer: a randomized controlled trial (PAM study).
    Koevoets EW; Schagen SB; de Ruiter MB; Geerlings MI; Witlox L; van der Wall E; Stuiver MM; Sonke GS; Velthuis MJ; Jobsen JJ; Menke-Pluijmers MBE; Göker E; van der Pol CC; Bos MEMM; Tick LW; van Holsteijn NA; van der Palen J; May AM; Monninkhof EM;
    Breast Cancer Res; 2022 May; 24(1):36. PubMed ID: 35619188
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.